Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

    Data Compilation
    #PharmaFlow

    Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

    Stock Recap
    #PipelineProspector

    Menu

    Niclosamide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 14Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    27/02/2026 Daewoong Pharmaceutical
    South Korea
    		 Daewoong Bio Co., Ltd. 20221110-211-J-1402 niclosamide 2022-11-10 Daewoong Bio Co., Ltd. South Korea 29, Jaehakdanji-ro, Hyangnam-eup, Hwaseong-si, Gyeonggi-do
    27/02/2026 Derivados Quimicos SAU
    Spain
    		 Daewoong Pharmaceutical Co., Ltd. 20200915-211-J-711(1) niclosamide 2020-11-06 Derivados Químicos SAU Spain Camino Viejo de Pliego, S/N Alcantarilla 30820 (Murcia), Spain
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.